Is end-to-end revenue cycle outsourcing on a slow march to doom?

Ahead of our 2026 Revenue Cycle Summit in Chicago, we've been chatting with many executives and board members about how their health systems are transforming their operations for 2026. Interestingly, a common ambition seems to be on everyone's radar: squeezing more out of existing vendor arrangements.

Eric Fontana
Eric Fontana
19 min read

Ahead of our 2026 Revenue Cycle Summit in Chicago, we’ve been chatting with many executives and board members about how their health systems are transforming their operations for 2026. Interestingly, a common ambition seems to be on everyone’s radar: squeezing more out of existing vendor arrangements. The questions many are pondering are flavors of: “Should we demand more from our current vendors or make wholesale changes?” And, while all types of vendors roll into this consideration, it seems like health systems using end-to-end (E2E) revenue cycle outsourcing (with offshoring) are taking a particularly close re-look.

Coincidentally, in early Q4 Black Book issued a press release highlighting an emerging trend: providers intent on pivoting away from revenue cycle outsourcing—offshoring in particular—with a couple of interesting topline numbers:

  • 34% of health systems plan not to renew at least one legacy RCM contract in the next 18 months.
  • 88% want to see data residency and auditable AI pipelines on US soil as mandatory in any revenue cycle-related RFP.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.